Summary
Updated Aug 30, 2026
Daniel J. Curran is Director of CATALYST PHARMACEUTICALS, INC. (CPRX). 5 SEC Form 4 filings on record going back to 2025, most recently on 17 July 2026.
Trading Pattern
InsiderAlpha's records for Daniel J. Curran go back to 2025: 5 primary Form 4 filings, an average of 2.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel J. Curran files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian Elsbernd - $2.50M of CPRX open-market activity in the last 12 months
- GILEAD SCIENCES, INC. - $2.00M of XLO open-market activity in the last 12 months
- Molly Harper - $622K of CPRX open-market activity in the last 12 months
- Carmen Jeffrey del - $256K of CPRX open-market activity in the last 12 months
- James Samuel Shannon - $44K of XLO open-market activity in the last 12 months
- Christopher James Frankenfield - $5K of XLO open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Daniel J. Curran?
Daniel J. Curran is a corporate insider, tracked as Director of CATALYST PHARMACEUTICALS, INC. (CPRX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Daniel J. Curran submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of Daniel J. Curran's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Daniel J. Curran and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial